Researchers develop a method for controlling gene activation

September 08, 2015

Researchers at the University of Helsinki, Finland, have developed a new method which enables the activation of genes in a cell without changing the genome. Applications of the method include directing the differentiation of stem cells.

The method was developed by young researchers Diego Balboa and Jere Weltner, who are working on their doctoral dissertations at Professor Timo Otonkoski's laboratory at the Meilahti medical campus of the University of Helsinki. The research was published in the Stem Cell Reports journal, which is a leading publication in the field of stem cell research.

The hottest topics in stem cell research at the moment are methods that can regulate the differentiation of cells. The differentiation process is based on how genes in a cell are activated and deactivated, so researchers are looking for ways to control the activation of the genes. The researchers dream of being able to activate and deactivate genes precisely at specific moments.

"We can produce undifferentiated stem cells from specialised cells, also known as iPS, or induced pluripotent stem cells, and we can regulate the differentiation of these cells by providing them with the right kinds of growth environments. However, we cannot control the differentiation process sufficiently - the process may go smoothly, but then at the very end, a single gene won't activate at the necessary time, and the cell remains immature," Otonkoski explains.

The system of clustered regularly interspaced short palindromic repeats, or CRISPR, means genes can be edited by cutting the DNA at certain points. The method can be used to remove a faulty gene from a cell or to introduce a transplanted gene that will express in the desired way.

Researchers in Otonkoski's laboratory have now developed a method that enables the regulation of a single gene's behaviour without changing the genome itself. The method employs CRISPR technology, but the regulation itself is controlled by the addition of chemicals. The desired gene is made receptive to the drug by introducing bits of RNA into the cell that will bind to the activator protein and the gene's regulatory area. The gene will then activate in the desired way when the chemicals that regulates the activator protein are provided to the cell.

"In our research, we used two common antibiotics, doxycycline and trimethoprim, and these chemicals enabled us to regulate the expression of many genes precisely and effectively. The method worked on all cells we tested, including stem cells - we used human cells in our development," Otonkoski explains.

Professor Otonkoski emphasises that the method is currently being used in experimental models - it is far too early to discuss therapeutic applications.

"The basic idea has now been developed, and the method has been demonstrated to be viable, and I believe that it can become a very important research tool. In my laboratory we use the method to regulate the differentiation of stem cells, but it has many potential applications in other research fields - for example, in cancer biology."

University of Helsinki

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to